Navigation Links
Cambrex Reports Third Quarter 2013 Financial Results
Date:11/1/2013

should call 1-888-510-1765 for domestic and +719-325-2494 for international.  Please use the pass code 8702967 and call approximately 10 minutes prior to start time.  A webcast will be available on the Investors section on the Cambrex website located at www.cambrex.com.  A telephone replay of the conference call will be available through Friday, November 8, 2013 by calling 1-888-203-1112 for domestic and +1-719-457-0820 for international.  Please use the pass code 8702967 to access the replay. 

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients ("APIs"), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.Forward Looking Statements
This document contains "forward-looking statements," including statements regarding expected performance, especially those set forth under the heading "Financial Expectations – Continuing Operations," including the Company's expectation that full year 2013 sales, excluding the impact of foreign currency, will increase between 9% and 12% versus 2012, that full year 2013 adjusted EBITDA will be between $64 and $68 million, that capital expenditures will be approximately $40 to $43 million, that depreciation will be $22 to $24 million in 2013, that the Company currently expects to pay only a small amount of cash taxes in the U.S. for the next few years, and that its estimated tax rate will be between 3
'/>"/>

SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cambrex Reports Fourth Quarter And Full Year 2012 Financial Results
2. Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013
3. Cambrex Reports Third Quarter 2012 Financial Results
4. Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
5. Cambrex Announces Significant New Supply Agreement
6. Cambrex To Present At Jefferies 2012 Global Healthcare Conference
7. Cambrex Reports First Quarter 2012 Results
8. IRIDEX Reports 2013 Third Quarter Results
9. Perrigo Reports Record First Quarter Revenue, Adjusted Earnings And Margins
10. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
11. Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  In any given hospital in the country ... at least one hospital-acquired infection, according to the Centers ... these infections prove fatal. And as increased surveillance has ... patient deaths per year, infection control efforts have drifted ... Consequently, a stronger emphasis is being placed upon innovative ...
(Date:7/24/2014)... /PRNewswire-iReach/ -- "North America Orthopedic Braces and Supports Market ... North America Orthopedic Braces and Supports market. The report ... (in units) and average price data (in US dollars), ... Supports , Ankle Braces and Supports , ... and Supports. Photo - ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- Delivery of the ... is placed. Photo - http://photos.prnewswire.com/prnh/20140723/129707 ... and in-depth market survey on Global and Chinese ... basic information of Hemodialysis Machine including its classification, ... global and China,s top manufacturers of Hemodialysis Machine ...
Breaking Medicine Technology:Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5
... Aug. 30 Bionovo, Inc. (Nasdaq: BNVI, BNVID) announced ... U.S. Food and Drug Administration (FDA) regarding the Company,s ... drug candidate Menerba®. The FDA indicated its agreement with ... the Company to progress to pivotal phase 3 clinical ...
... Inc. (OTC Bulletin Board: AEMD ), the pioneer ... cancer, announced today that its Chairman and Chief Executive Officer, ... Global Investment Conference at 3:40 p.m. EDT on September 14, ... Palace Hotel in New York City from September 12-15, 2010. ...
Cached Medicine Technology:Bionovo Receives Positive Guidance from FDA on Menerba® 2Bionovo Receives Positive Guidance from FDA on Menerba® 3Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 2Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 3Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 4Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference 5
(Date:7/24/2014)... 2014 "My child had a fever ... said an inventor from Cynthiana, Ky. "I could not ... brain damage, hearing loss, vision problems and kidney damage, ... me to the fever immediately." , He developed the ... the child’s temperature. The unit alerts parents if child ...
(Date:7/24/2014)... Arlington professor who co-authored a book about the ... revitalization has been awarded the Community Development Society,s ... professor in the School of Urban and Public ... the society,s national conference, along with her co-author ... in the Urban Studies and Planning Program at ...
(Date:7/24/2014)... associated with upsurges in hospital admissions among young people. ... is published online today in the scientific journal ... British Columbia Associate Professor of Psychiatry Dr. Russ Callaghan, ... a five-year period (2002-07) involving people aged 12 to ... in which Ontarians turned 19 the legal drinking ...
(Date:7/24/2014)... parasite becomes resistant to an investigational drug. The ... St. Louis, also is relevant for other infectious ... study appears July 24 in Nature Communications ... causes malaria, make a class of molecules called ... healthy, whether plants, animals or bacteria. In malaria, ...
(Date:7/24/2014)... detecting bacteria are often slow and time-consuming. Therefore, ... illness-causing microorganisms is very important for improving food ... National Food Institute, has studied new methods of ... unknown bacteria in water, feed and food samples. ... understanding of which factors in pork meat processing ...
Breaking Medicine News(10 mins):Health News:Strategy for community development partnerships earns award for UT Arlington professor 2Health News:One route to malaria drug resistance found 2Health News:One route to malaria drug resistance found 3
... Damir Matic, a scientist with Lawson Health Research Institute in ... performed throughout North America and around the world. Matic ... close the gum tissue of cleft palate patients. His research ... is older. , Matic is a craniofacial/plastic surgeon at London ...
... mostly males, are hooked , , MONDAY, May 12 (HealthDay ... adults are problem gamblers according to researchers at the ... Problem gambling is defined as gambling associated with three ... you intended or stealing money to gamble. , The ...
... Inc., a developer of advanced medical devices for ... that it has enrolled its,first patient in the ... U.S. registry study of the company,s OmniWave(TM) Endovascular,System ... limb ischemia (ALI). All patients enrolled in the ...
... Md., May 12 Naturlose, a natural sugar,approved as a ... to,reduce the spikes of serum glucose that follow consumption of ... SPEX ) is currently,studying the efficacy and safety of ... is ongoing, Spherix has engaged market,research companies to seek feedback ...
... RE: American Psychological Association 116th Annual Convention in Boston, ... Meeting Level 1, Boston Convention and Exhibition Center. ... and two high-speed printers. We will also provide working ... and APA staff resources. This room will also be ...
... Pa., May 12 Acting Insurance,Commissioner Joel Ario ... series of public informational hearings across the state ... how the proposed,consolidation of Highmark Inc. and Independence ... marketplace., The hearings will be held July ...
Cached Medicine News:Health News:Research shows timing improves cleft palate surgery 2Health News:Problem Gambling Common Among Young Adults 2Health News:OmniSonics Medical Technologies Announces First Patient Enrolled in SONIC II REGISTRY 2Health News:Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients 2Health News:Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients 3Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 2Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 3Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 4Health News:Insurance Department to Hold Statewide Meetings on Proposed Consolidation of Independence Blue Cross, Highmark 2
... GORE SEAMGUARD® Staple Line Reinforcement ... in reducing postoperative pulmonary air leaks ... hospital care. This inert, biocompatible, ePTFE ... non-biological.,It is easy to load and ...
... for the repair of abdominal hernias. It ... two distinct sides. One side of ... of sodium hyaluronate and carboxymethylcellulose (similar to ... side is bioresorbable, providing a temporary physical ...
... Company, we recognize that there are circumstances ... in-growth between the prosthesis and the repair ... all the products in Bards complete line ... proven, versatile repair.,The Reconix Patch is Bards ...
... PLUS Biomaterial is the first hernia ... controlling potential operative contamination of the ... two antimicrobial preservative agents, silver carbonate ... inhibit bacterial colonization on the patch ...
Medicine Products: